MICROBPLEX, INC.

MicroBplex is an in vitro diagnostics company that identifies microbial infections by detecting nascent Antibody Secreting Cells (ASCs) in patient blood. ASCs arise early and circulate in blood as the first indication of immune recognition following exposure to an infectious agent, enabling faster and more accurate diagnosis than conventional antibody-based tests. The company's first products target Lyme disease — providing earlier detection, distinguishing new infection from prior exposure, and assessing therapeutic effectiveness — and Clostridium difficile, distinguishing active infection from colonization and identifying patients with protective immunity. The technology was conceived by scientific founders Drs. Frances Eun-Hyung Lee (Emory University) and John L. Daiss (University of Rochester).